JYRA Health review
Graded on whether a price is published, checkable, and still true at month two — how we grade · how we verify prices
JYRA Health headlines compounded semaglutide at $99 a month. One month on its own is $169 — and the page will tell you so, once you click the tab it did not open on.
The cheaper figure is the tab the page opens on. Choosing it means paying $297 up front for three months; a month you can stop after costs $169, and that rung only appears once you click the other tab.
- Advertised $99, actually $169
- Month-to-month price published
- States not published
- Prices read September 2026
Read first-hand, not from a feed.
Distinct plans priced.
Added by the time you're billed.
This link pays us nothing. It's here because the price is checkable.
The verdict
A complete two-rung ladder for both molecules, with the billed total printed beside every rate. It just loads on the committed plan, and it names no company anywhere in its terms.
This link pays us nothing. It's here because the price is checkable.
Quick facts
Key facts
- Compounded semaglutide, one month
- $169
- Compounded semaglutide, three-month plan
- $99 a month, $297 billed
- Compounded tirzepatide, one month
- $229
- Compounded tirzepatide, three-month plan
- $133 a month, $399 billed
- Price at a higher dose
- Stated as unchanged, at every dose
- Legal entity
- Not named in the terms or anywhere else read
- Governing law
- Delaware, named in the terms
- States served
- A banner claims 50; no state is named
Pros and cons
What we like
- Publishes a single-month price for both molecules, not only a plan rate.
- Prints the amount actually billed beside every per-month rate.
- States that the price is flat at every dose and does not rise at renewal.
- Names the consultation, the prescription, express shipping and ongoing provider support as included.
- Shows the saving each plan produces as its own figure rather than as a percentage.
What could be better
- Both product pages load on the three-month tab, so the committed rate is the one on screen.
- The terms of service name no company, no corporate suffix and no postal address.
- The fifty-state claim is a banner with no list behind it.
- No compounding pharmacy is named on any page we read.
- The host answers HTTP 200 for paths that do not exist, so a status code proves nothing here.
What it is
JYRA Health sells compounded semaglutide and compounded tirzepatide by telehealth, alongside a longevity line that includes glutathione, NAD and sermorelin. Each weight-loss molecule has its own treatment page with a single pricing card, and that card is the whole commercial story: a plan toggle, a per-month rate, the total that will actually be billed, and a list of what the figure covers.
The disclosure around that card is thinner than the card itself. The terms of service choose Delaware law and name no company at all — no corporate suffix, no address, nothing a reader could look up. For a seller that is otherwise this specific about money, the silence about who is taking it is conspicuous.
Every price we found at JYRA Health
| Plan | Advertised | What you actually pay | The gap | Read on |
|---|---|---|---|---|
| Compounded semaglutide, one monthOne month with no commitment. Revealed by the product page's own one-month tab; the page loads on the three-month tab instead. | not published | $169 | not comparable | September 2026 |
| Compounded semaglutide, three-month planThe $99 is the per-month working of a plan billed at $297; $169 is what one month costs on its own. The card states the saving as $210. | $99 | $169 | September 2026 | |
| Compounded tirzepatide, one monthOne month with no commitment, revealed by the same tab control on the tirzepatide page. | not published | $229 | not comparable | September 2026 |
| Compounded tirzepatide, three-month planThe $133 is the per-month working of a plan billed at $399, with the saving stated as $288; a single month is $229. | $133 | $229 | September 2026 |
This link pays us nothing. It's here because the price is checkable.
What it actually costs at JYRA Health
Both rungs exist for both drugs: compounded semaglutide is $169 for one month or $99 a month on a three-month plan billed at $297, and compounded tirzepatide is $229 or $133 a month billed at $399.
That is a more complete ladder than most of this roster publishes, and the card does the arithmetic honestly — the per-month rate and the amount actually charged sit beside each other, so a reader can see that the cheaper rate is a three-month commitment rather than a monthly one. The card also repeats two promises that hold across both pages: no hidden fees, and the same flat price at every dose with no increase at renewal.
The deduction is about which rung the reader meets first. Both product pages load on the three-month tab, so the figure on screen is the committed rate and the single-month price is one click away rather than in view. A visitor who never notices the toggle leaves believing semaglutide here costs ninety-nine dollars a month, when the price of a month they can walk away from is seventy dollars higher. That is a mild version of how prepaid terms and renewal cycles are structured elsewhere in this category.
The sitewide banner claims board-certified providers in all fifty states and names none of them, and no page publishes a state list. A count is not a list.
Who it's wrong for
- Anyone who needs to know who they are contracting with. The terms name no company, no corporate suffix and no address.
- Anyone comparing on the advertised figure alone. The rate the page opens on is a three-month commitment, not a month.
- Anyone who needs to confirm their state. The site publishes a fifty-state claim and enumerates nothing.
- Anyone who needs the compounding pharmacy named. No page we read names one.
Medications available
- Compounded semaglutide injectionCompounded$169 for one month
Also sold as a three-month plan at $99 a month, billed $297 up front.
- Compounded tirzepatide injectionCompounded$229 for one month
Also sold as a three-month plan at $133 a month, billed $399 up front.
Pharmacy, prescribers and safety checks
- Legal entityNot disclosed on any page read
- Governing lawDelaware
- Pharmacy namedNot disclosed
- Drug formCompounded; not FDA-approved
- Who prescribesDescribed only as board-certified providers, none named
- States servedA banner claims all 50; no list is published
Common questions
How much is one month at JYRA Health?
A single month of compounded semaglutide is $169 and a single month of compounded tirzepatide is $229. Both figures are on the product pages, but only after you click the one-month tab, because each page loads on the three-month plan instead.
Is the JYRA Health $99 price a monthly price?
Not in the sense of a month you can buy on its own. It is the per-month working of a three-month plan billed at $297 in a single payment, and the same card prints that total right next to it.
Does JYRA Health charge more at a higher dose?
The card says no. Its own wording is the same flat price at every dose with no increase at renewal, and that line appears on both the semaglutide and the tirzepatide pages rather than only on one.
Who operates JYRA Health?
The site does not say. Its terms of service choose Delaware law and name no corporate entity at all, no address and no corporate suffix, so there is nothing a reader could look up in a state register before paying.
Does JYRA Health serve all 50 states?
It publishes a banner claiming board-certified providers in all fifty states and names none of them. No page we read publishes a list of states, an exclusion list, or any statement about where a given clinician is licensed.
Why we gave JYRA Health a B
Read the full grading rationale
JYRA Health publishes a complete two-rung ladder for both molecules, which puts it ahead of most of this roster: compounded semaglutide is $169 for a single month or $99 a month on a three-month plan billed at $297, and compounded tirzepatide is $229 or $133 a month billed at $399. Every card prints the per-month rate and the amount actually billed side by side, and repeats two promises that hold up across both pages — "No hidden fees, ever" and "Same flat price at every dose — no increase at renewal" — with free consultation, prescription, express shipping and ongoing provider support named as included rather than implied. What keeps it out of the A band is where the seller points the reader. Both product pages load on the three-month tab, so the figure a visitor sees first is the committed rate; the single-month price exists but has to be clicked for. Two further gaps matter more than they look. Its terms name no company — no LLC, no Inc., no address, just "JYRA Health" and a choice of Delaware law — and its sitewide banner claims "Board-Certified Providers in All 50 States" while naming none of them and publishing no state list. Its host also answers HTTP 200 for paths that do not exist, so nothing here was inferred from a status code.
What that means
Screening is by entity — the company’s own domain plus the address it publishes — never by brand name, because a brand name matches every namesake. Where a company publishes no address, the address half of that match is never exercised, and the result is recorded as the weaker kind of absence rather than a clean record. A known-positive control passed in the same run, so a real match would have surfaced. A letter would be worth knowing about; it would not by itself disqualify a seller.How we reviewed JYRA Health
- We read both treatment pages, the homepage and the terms of service in full on 2026-09-12, and took every figure from the treatment page that prints it.
- The one-month prices sit behind a tab. We opened it with the page's own control on a fresh load of each page and confirmed the card's rate and its total both changed together, from $99 and $297 to $169 on semaglutide and from $133 and $399 to $229 on tirzepatide, with the rest of the card unchanged. That is revealed text, not markup read out of a hidden node.
- This host is hostile to status-code reasoning: a nonsense path returned HTTP 200 with a short body rather than a 404. No claim in this review rests on a status code, and every page named here was read for its content.
- The FDA warning-letter screen ran on the company's own domain, with a known-positive and a known-negative control passing in the same run. It returned no candidate letters, and because this company publishes neither an entity name nor an address the second half of the match could never have run.
The 2 pages we read — all on
- Semaglutide page
1 Month 3 Month Save $210 $169 /mo $169 total No hidden fees, ever Same flat price at every dose — no increase at renewal
- Tirzepatide page
1 Month 3 Month Save $288 $229 /mo $229 total No hidden fees, ever Same flat price at every dose — no increase at renewal
This link pays us nothing. It's here because the price is checkable.
Alternatives to JYRA Health
| Provider | Grade | Cheapest price |
|---|---|---|
| Trellis Vitality | BMinor gap | $93/mo |
| The Edit | BMinor gap | $69/mo |
| Alternate Health Club | CCaveat | $99/mo |
| Boston Medical Group | FFail | $99/mo |
| Brightmeds | AVerified | $99/mo |